"It would be completely wrong not to alert people well in advance that there is a possibility that their benefit entitlement may change, " a spokesman said.
Perhaps as a condition of direct-to-consumer advertising, drug companies should have to set aside some funds to pay for advertisements that would alert consumers when something goes wrong.